Related Experiment Videos
[Relationship and interactions between elevated fasting glucose and hypertension for cardiocerebral vascular disease]
Yi-qiang Zhan1, Jin-ming Yu, Da-yi Hu
1School of Public Health, Fudan University, Shanghai, China.
Insights
Elevated fasting glucose and hypertension showed additive interaction on cardiovascular disease risk in Beijing adults. This interaction, particularly with diabetes, highlights a significant combined impact on heart health.
Area of Science:
- Cardiovascular epidemiology
- Metabolic disease research
- Public health
Context:
- Cardiocerebral vascular disease poses a significant health burden.
- Understanding the interplay of metabolic and hypertensive disorders is crucial for prevention.
- Previous research has explored individual risk factors, but interaction effects require further investigation.
Purpose:
- To investigate the relationship and interaction between elevated fasting glucose and hypertension on cardiocerebral vascular disease.
- To analyze both multiplicative and additive interactions between these two risk factors.
- To quantify the interaction effect using measures like RERI, AP, and S.
Summary:
- A cross-sectional study of 10,054 individuals examined the combined effects of fasting glucose and hypertension on cardiocerebral vascular disease.
- No statistically significant multiplicative interaction was found between elevated fasting glucose and hypertension.
- Significant additive interaction was observed between diabetes and hypertension for cardiovascular disease, but not for stroke.
Impact:
- The findings indicate that while hypertension and diabetes are independent risk factors for cardiovascular events, their combination has a synergistic effect on cardiovascular disease.
- This highlights the importance of managing both conditions concurrently to mitigate cardiocerebral vascular disease risk.
- Public health strategies should consider the additive interaction of diabetes and hypertension for effective cardiovascular disease prevention programs.
Objective:
To explore the relationship and interaction of elevated fasting glucose and hypertension on cardiocerebral vascular disease.
Methods:
10 054 males and females were recruited for our cross-sectional study during May 2007 to August 2007. Unconditional logistic regression was used to analysis the relationship between fasting glucose and hypertension on cardiocerebral vascular disease. A product of fasting glucose and hypertension was added to the logistic regression model to evaluate the multiplicative interaction and relative excess risk of interaction (RERI), attributable proportion (AP) of interaction and synergy index (S) was applied to evaluate the additive interaction of the two factors. Bootstrap was used to calculate 95% confidence intervals (CI) of RERI, AP and S.
Results:
After adjusting age, gender, smoking, drinking, body mass index (BMI) and region, the product of fasting glucose and hypertension was not statistically significant, which means there was no multiplicative interaction between the two. But the additive indexes RERI, AP and S with 95%CI of diabetes and hypertension were 0.64 (0.03, 1.25), 0.27 (0.01, 0.47) and 1.83 (1.02, 5.13) respectively, which means significant additive interaction was shown between the two on cardiovascular disease but not no stroke. And there were no additive interaction between impaired fasting glucose on cardiovascular disease or stroke.
Conclusions:
Hypertension was independently related to cardiovascular disease and stroke in Beijing citizens, and diabetes were independently related to stroke. There was additive interaction between diabetes and hypertension on cardiovascular disease.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hyperglycemia
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease I: Introduction